{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:52:50Z","timestamp":1790614370483,"version":"4.1.0"},"reference-count":47,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"797","content-domain":{"domain":["www.science.org"],"crossmark-restriction":true},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2025,5,7]]},"abstract":"<jats:p>Capsular group B meningococcus (MenB) remains an important cause of disease globally, and additional vaccines against MenB would aid in reducing the incidence of infection. Previous work has demonstrated that a MenB adenoviral-vectored vaccine, ChAdOx1 MenB.1, elicited high serum bactericidal responses in preclinical models after a single dose, supporting further clinical development of this vaccine. Here, we report the results of a trial designed to assess the safety and immunogenicity of ChAdOx1 MenB.1 in healthy adults aged 18 to 50. In this phase 1\/2a, single-center trial, participants received one or two doses of ChAdOx1 MenB.1 at days 0 and 180. One dose of ChAdOx1 MenB.1 was also given at day 180 to some individuals primed with one dose of 4CMenB at day 0. Participants recorded their symptoms in an electronic diary after vaccination, and safety blood readouts were monitored. Serum bactericidal antibody (SBA) assays were performed against a panel of MenB target strains. ChAdOx1 MenB.1 was well tolerated with no safety concerns and elicited protective SBA titers against a MenB strain expressing a homologous factor H\u2013binding protein (fHbp) variant in 100% of participants after two doses. However, cross-reactivity analysis indicated a low SBA response to strains expressing heterologous fHbp, suggesting that a multivalent vaccine may be needed. In sum, ChAdOx1 MenB.1 is immunogenic in humans, and addition of another fHbp variant or of another antigen in this platform could provide an approach to extend protection against endemic MenB disease.<\/jats:p>","DOI":"10.1126\/scitranslmed.adn1441","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:59:07Z","timestamp":1746640747000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark","source":"Crossref","is-referenced-by-count":5,"title":["A phase 1\/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine"],"prefix":"10.1126","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-507X","authenticated-orcid":true,"given":"Christina","family":"Dold","sequence":"first","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-9992","authenticated-orcid":true,"given":"Blanch\u00e9","family":"Oguti","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."},{"name":"Division of Infection and Immunity, Faculty of Medical Sciences, University College London, London WC1E 6JF, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Silva-Reyes","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stanzelova","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0442-9280","authenticated-orcid":true,"given":"Meriel","family":"Raymond","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0375-287X","authenticated-orcid":true,"given":"Catherine C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-927X","authenticated-orcid":true,"given":"Maria","family":"Moore","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barton","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8148-120X","authenticated-orcid":true,"given":"Edward M.","family":"Choi","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Plested","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-5409","authenticated-orcid":true,"given":"Kiarash","family":"Tanha","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Louth","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, UK Health Security Agency, Manchester M13 9WL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Holland","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, UK Health Security Agency, Manchester M13 9WL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-8353","authenticated-orcid":true,"given":"Robert","family":"Cook","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, UK Health Security Agency, Manchester M13 9WL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7447-2787","authenticated-orcid":true,"given":"Jessica","family":"King","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, UK Health Security Agency, Manchester M13 9WL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-2512","authenticated-orcid":true,"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[{"name":"Meningococcal Reference Unit, UK Health Security Agency, Manchester M13 9WL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0691-6568","authenticated-orcid":true,"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, UK Health Security Agency, Manchester M13 9WL, UK."},{"name":"Meningococcal Reference Unit, UK Health Security Agency, Manchester M13 9WL, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-9629","authenticated-orcid":true,"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[{"name":"Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Beernink","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of California, San Francisco, San Francisco, CA 94143, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-0365","authenticated-orcid":true,"given":"Xinxue","family":"Liu","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-719X","authenticated-orcid":true,"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-8080","authenticated-orcid":true,"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX37LE, UK."},{"name":"School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00883-7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.111500"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"e_1_3_2_5_2","unstructured":"Health Protection Report Invasive meningococcal disease in England: Epidemiological year 2019 to 2020 (2021); https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/951142\/hpr0121_imd-ann.pdf."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/126.5.514"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv039"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901229"},{"key":"e_1_3_2_10_2","unstructured":"Department of Health and Social Care and Public Health England Meningococcal B vaccine: JCVI position statement: JCVI position statement on the use of meningococcal B (MenB) vaccine in the UK (2014); www.gov.uk\/government\/publications\/meningococcal-b-vaccine-jcvi-position-statement."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70180-1"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040385"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade3901"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102210"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300034"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.181"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00115-10"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.02.032"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30160-2"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.284"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24906-y"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00680-0"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00430-16"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.091"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.6.15482"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.059"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.027"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00479-7"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2.1.87"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-009282"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2452-2463.1999"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.072"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302378"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-062117"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5652"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00418-07"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01179-4"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.049"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.09.020"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.098"},{"key":"e_1_3_2_43_2","unstructured":"Center for Biologics Evaluation and Research Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials FDA-2005-D-0272 (US Food and Drug Administration 2007)."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9202-7_12"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1086\/656741"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181f59f6d"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.027"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.085"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.adn1441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:59:39Z","timestamp":1746640779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.adn1441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":47,"journal-issue":{"issue":"797","published-print":{"date-parts":[[2025,5,7]]}},"alternative-id":["10.1126\/scitranslmed.adn1441"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.adn1441","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"2023-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"eadn1441"}}